BrightRoll builds software that automates and improves digital video advertising globally.

BrightRoll builds software that automates video advertising globally. BrightRoll is the only independent and unified programmatic video advertising platform for reaching audiences across web, mobile and connected TV. The company powers digital video advertising for the world‚Äôs largest brands, including more than 80 of the top 100 US advertisers and 18 of the top 20 advertising technology companies.  The platform enables advertisers to reach 4 in 5 video viewers online and consistently ranks among the top two video ad platforms in ads served. As a result, BrightRoll technology collects and analyzes hundreds of billions of data points monthly enabling real-time decisions that drive ROI for advertisers.

BrightRoll

Senior Research Scientist

Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.

Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages. The company is developing a simple blood test to detect early-stage cancer and make treatments more effective and provides a platform that helps design healthy conditions for an individual based on his/her cell-free genome. The company aims to reinvent disease management through systematized early detection and intervention. Charles Roberts, Gabriel Otte, Riley Ennis, and Michael Otte launched the company in 2014 in South San Francisco, California.

Freenome

IDEAYA Biosciences is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality

IDEAYA Biosciences (IDEAYA) is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality medicines targeting DNA damage and repair for genetically defined patient populations and for enhancing immunotherapy response, and immuno-oncology therapies targeting the tumor micro-environment. IDEAYA, located in South San Francisco and La Jolla, California, has assembled leading scientists and advisors with extensive knowledge and expertise in cancer biology and small molecule drug discovery.

IDEAYA Biosciences

Research Scientist/Senior Research Scientist

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients. Recent work in the laboratory of Professor Douglas Melton led to the discovery of a method to generate billions of functional, insulin-producing beta cells in the laboratory. This breakthrough technology has been exclusively licensed to Semma Therapeutics for the development of a cell-based therapy for diabetes. Ongoing research at Semma Therapeutics is focused on combining these proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. Semma Therapeutics is working to bring this new therapeutic option to the clinic and improve the lives of patients with diabetes.

Semma Therapeutics

High Throughput Biology Senior Research Scientist

Heirloom, a direct air capture company permanently removing CO2 from the atmosphere

Heirloom aims to remove 1 billion tons of carbon dioxide using the world's most cost-effective Direct Air Capture solution, a mineralization process known as enhanced weathering.

Heirloom

Senior Research Scientist - Geochemistry

Kensho

Kensho combines natural language search, graphical user interfaces, and secure cloud computing to create a new class of analytics tools.

Kensho combines natural language search queries, graphical user interfaces, and secure cloud computing to create a new class of analytics tools for investment professionals. Addressing the three biggest challenges surrounding investment analysis on Wall Street today‚Äîspeed, scale, and automation‚ÄîKensho's intelligent computer systems are capable of answering complex financial questions posed in plain English. Kensho is a data analytics and machine intelligence company. Kensho deploys scalable machine learning and analytics systems across the most critical government and commercial institutions in the world to solve some of the hardest analytical problems of our time. Founded in the spring of 2013 out of MIT and Harvard, Kensho's senior team members come from veteran positions at Google, Apple, and the United States Federal Reserve. They are a diverse and spirited group of engineers, scientists, and financial professionals who are accomplished analytical thinkers and passionate problem solvers. Together, their multi-talented team includes Ph.D. physicists, a three-time International Olympiad in Informatics (IOI) world champion, Ph.D. economists, internationally competitive chess players, the author of Quantitative Finance for Physicists, a member of the original Apple iPhone engineering team, and one of the youngest ever entrants to Harvard College (age 15).

Seranova Bio develops companion diagnostics or therapeutics to treat autoimmune disease or other autoantibody-driven diseases.

Seranova Bio partners with clinicians and drug developers to develop companion diagnostics or therapeutics to treat autoimmune disease or other autoantibody-driven diseases. The company's REAP platform was developed to detect autoantibodies that recognize â€œconformationalâ€ protein epitopes (i.e., three-dimensional epitopes present when a protein is folded into its native state) which are recognized by up 90% of autoantibodies. The platform includes over 3000 extracellular and secreted proteins to comprehensively characterize autoantibody responses in patients.

Seranova Bio

Senior Research Associate

NextSense unlocks brain health with real-world data insights and practical, scientific wisdom for daily living.

NextSense unlocks brain health with real-world data insights and practical, scientific wisdom for daily living. It aims to catalyze brain health in science and culture. The company was founded in 2020 and is headquartered in Mountain View, California.

Location

Company Stage

Age of Data

Experience

Industry

Company

Senior Research Scientist

BrightRoll

$144k - $299k

$143,625 - $299,375

Freenome

$136k - $210k

$136,000 - $210,000

IDEAYA Biosciences

$136k - $178k

$136,463 - $178,460

Semma Therapeutics

$117k - $176k

$117,000 - $175,500

Heirloom

$115k - $150k

$115,000 - $150,000

Kensho

$20k

$20,000

Kensho

$20k

$20,000

Seranova Bio

N/A

N/A

NextSense

N/A

N/A